Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Azathioprine therapy selectively ablates human Vd2? T cells in Crohn's disease.

McCarthy NE, Hedin CR, Sanders TJ, Amon P, Hoti I, Ayada I, Baji V, Giles EM, Wildemann M, Bashir Z, Whelan K, Sanderson I, Lindsay JO, Stagg AJ. Azathioprine therapy selectively ablates human Vd2? T cells in Crohn's disease. J Clin Invest. 2015 Aug 03; 125(8):3215-25.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.